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Background
Symptom burden is high in chronic kidney disease (CKD) due to multiple symptoms 
affecting everyday life. Symptoms, however, are known to form clusters in cancer and 
other chronic disease but little is known about CKD symptom clusters. 
Aim
To explore symptom clusters in advanced stages of CKD. 
Methods
Using a cross-sectional design, 436 people with advanced stages of CKD completed the 
Chronic Kidney Disease - Symptom Burden Index which assesses the multidimensional 
nature of 32 symptoms. Exploratory factor analysis was used to identify symptom clusters. 
A high cutoff of 0.50 for factor loading was used for all analyses. Core symptoms in each 
cluster were determined based on stability across dimensions and clinical plausibility. 
Results
Participants were mostly men (53%) with a mean age of 48 years (SD±14.86) and 
receiving dialysis (75.5%). Five symptom clusters were identified across all symptom 
dimensions (occurrence, distress, severity and frequency); namely fluid volume 
symptoms, neuromuscular symptoms, gastrointestinal symptoms, sexual symptoms, 
and psychological symptoms. Several symptoms were also interconnected with multiple 
clusters. Fatigue cross loaded onto all five clusters, whereas sleep disturbance and 
restless leg symptoms cross-loaded across three clusters. 
Conclusion
Adopting a symptom cluster approach is a promising method to advance symptom 
assessment and management in CKD. Routine clinical assessment and management 
strategies targeted at the cluster level should have synergistic effects in reducing 
symptoms. Fatigue is a highly prevalent and pervasive symptom for those with CKD that 
is interconnected with global symptom burden, suggesting better management of multiple 
symptom clusters may also reduce fatigue.
